BIOT 5920 — Foundations in Vaccine Regulatory Science
3 semester hoursGraduateLectureusually offered: springOnlineOnline
Explores the science behind how regulatory pathways were developed and how vaccines were approved for human use. The pathway for vaccine approvals by national regulatory authorities has been well established for decades. The SARS-CoV-2 pandemic created an immediate need to create new vaccines, which also created a new need for the regulatory approval of these vaccines. Examines how SARS-CoV-2 vaccines caused an increased interest in the regulatory science behind vaccine regulatory approval, specifically exploring the use of emergency use authorization (EUA) in getting SARS-CoV-2 vaccines to market. Discusses how the use of EUAs changed the regulatory science landscape of vaccines.
Offering history
| Term | Sections | Enrolled | Capacity | Full | Open seats/section |
|---|---|---|---|---|---|
| Spring 2024 | 1 | 13 | 20 | 65% | 7.0 |
| Spring 2025 | 1 | 19 | 20 | 95% | 1.0 |
| Spring 2026 | 1 | 18 | 20 | 90% | 2.0 |
Snapshots from scheduled scrapes — not live seat availability. "Full" can exceed 100% when sections over-enroll.
Meeting times
Share of recent sections by weekday: M 0% · T 0% · W 0% · Th 0% · F 0%
Common patterns: async (100% of sections) — in patterns, R means Thursday
Professors
Spring
- Fleury Augustin Nsole Biteghe (74% of students) · reviews
- Sanaa Jehi (26% of students) · reviews
Percentages are each professor's average share of the season's enrolled students in recent terms.
Links
Official catalog (BIOT course descriptions) · Student reviews on RateMyHusky · All BIOT courses · Plan it at numap.app